Exelixis: A Strong Contender in the Cancer Drug Market

Explore the exciting world of Exelixis (EXEL +2.24%) with our contributing expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market trends and potential investment opportunities!